-
161
Antibiotic-Induced Immunosuppression—A Focus on Cellular Immunity
Published 2024-11-01Get full text
Article -
162
The (Sialyl) Tn antigen: Contributions to immunosuppression in gastrointestinal cancers
Published 2023-01-01“…Studying the interaction between Tn/STn antigens and the TIME of gastrointestinal cancers can help develop better and more robust therapies that can counteract immunosuppressive mechanisms to sensitize these tumors to anticancer therapies.…”
Get full text
Article -
163
Systemic and local immunosuppression in glioblastoma and its prognostic significance
Published 2024-02-01“…However, various local and systemic mechanisms of immunosuppression operate in cancer patients. Tumor-associated immunosuppression involves deregulation of many components of immunity, including a decrease in the number of T lymphocytes (lymphopenia), an increase in the levels or ratios of circulating and tumor-infiltrating immunosuppressive subsets [e.g., macrophages, microglia, myeloid-derived suppressor cells (MDSCs), and regulatory T cells (Tregs)], as well as defective functions of subsets of antigen-presenting, helper and effector immune cell due to altered expression of various soluble and membrane proteins (receptors, costimulatory molecules, and cytokines). …”
Get full text
Article -
164
COVID-19 in Immunosuppressed and Cancer Patients: A review
Published 2020-07-01Subjects: “…covid-19, cancer, immunosuppression…”
Get full text
Article -
165
Microbial Metabolite 3-Indolepropionic Acid Mediates Immunosuppression
Published 2022-07-01Subjects: Get full text
Article -
166
Outcome of immunosuppressive therapy in children with acquired aplastic anemia
Published 2024-01-01Get full text
Article -
167
CD200 promotes immunosuppression in the pancreatic tumor microenvironment
Published 2020-05-01“…Background A significant challenge to overcome in pancreatic ductal adenocarcinoma (PDAC) is the profound systemic immunosuppression that renders this disease non-responsive to immunotherapy. …”
Get full text
Article -
168
Myeloidcells in the immunosuppressive microenvironment in glioblastoma: The characteristics and therapeutic strategies
Published 2023-02-01Subjects: Get full text
Article -
169
SARS-CoV-2 and Cancer: Beyond Immunosuppression
Published 2021-03-01Subjects: Get full text
Article -
170
The Immunotherapy and Immunosuppressive Signaling in Therapy-Resistant Prostate Cancer
Published 2022-07-01Subjects: Get full text
Article -
171
Oral-Intestinal Microbiota in Colorectal Cancer: Inflammation and Immunosuppression
Published 2022-02-01Subjects: Get full text
Article -
172
Ovarian endometrioma infiltrating neutrophils orchestrate immunosuppressive microenvironment
Published 2020-04-01Subjects: Get full text
Article -
173
Costs and consequences of immunosuppressive therapy in children with aplastic anemia
Published 2011-06-01Get full text
Article -
174
Fournier gangrene in an immunosuppressed patient due to cancer chemotherapy
Published 2013-10-01Get full text
Article -
175
Immunosuppressive therapies in scorpion envenomation: new perspectives for treatment
Published 2024-11-01Get full text
Article -
176
IMMUNOSUPPRESSIVE EFFECTS OF ARGININE DEIMINASE FROM STREPTOCOCCUS PYOGENES
Published 2015-10-01Subjects: Get full text
Article -
177
Viewpoint about biologic agents for psoriasis: are they immunosuppressants or immunomodulators?
Published 2023-06-01“…One of the most challenging components of marketing and prescribing these biologic therapies has been in classifying them as immunomodulators or immunosuppressants. The purpose of this narrative review was to discuss the features that distinguish immunomodulators from immunosuppressants to successfully categorize the biologic therapies used for psoriasis management and subsequently enhance patient and physician understanding of the risks associated with the use of these drugs.…”
Get full text
Article -
178
Modulation of immunosuppressive cells and noncoding RNAs as immunotherapy in osteosarcoma
Published 2022-11-01Subjects: Get full text
Article -
179
Hypoxia-mediated repression of pyruvate carboxylase drives immunosuppression
Published 2024-06-01“…We identify hypoxia-mediated suppression of pyruvate carboxylase (PC), and subsequent induction of lactate production, as a metabolic regulator of immunosuppression. Methods We used qPCR, immunoblot, and reporter assays to characterize repression of PC in hypoxic primary tumors. …”
Get full text
Article -
180
Cutaneous Coinfection of Cytomegalovirus and Mycobacterium chelonae Accelerated by Immunosuppression
Published 2021-01-01“…Pyoderma gangrenosum was clinically diagnosed after the first biopsy, indicating a noninfective ulcer. Immunosuppressive therapy (prednisolone and cyclosporine A) induced complete epithelialization in three months. …”
Get full text
Article